ChemWerth Inc., a supplier of generic active pharmaceutical ingredients (APIs), filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) for Clevidipine, making it the company’s 500th DMF in its history. It filed its first DMF in 1987 and continues to rank among world leaders for DMFs available for reference.   According to the company, its average review cycle for DMF filings is 0.79 in comparison with the industry average of 2.5 cycles, enabling it to turn DMFs around qu...